Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 264 | 256 | 381 | 397 | 350 |
| Cost of Goods | 164 | 112 | 198 | 155 | 134 |
| Gross Profit | 100 | 144 | 182 | 241 | 216 |
| Operating Expenses | 2,361 | 7,125 | 1,859 | 2,212 | 2,062 |
| Operating Income | -2,097 | -6,869 | -1,479 | -1,816 | -1,711 |
| Interest Expense | 456 | 60 | 138 | 124 | 97 |
| Other Income | -3 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -2,556 | -6,929 | -1,617 | -1,939 | -1,807 |
| Net Income Continuous | -2,556 | -6,929 | -1,617 | -1,939 | -1,807 |
| Net Income | $-2,556 | $-6,929 | $-1,617 | $-1,939 | $-1,807 |
| EPS Basic Total Ops | -1,978.03 | -9,350.67 | -4,495.51 | -5,844.17 | -5,754.26 |
| EPS Basic Continuous Ops | -1,931.71 | -9,310.53 | -4,508.50 | -5,974.59 | -5,718.60 |
| EPS Diluted Total Ops | -1,978.03 | -9,350.67 | -4,495.51 | -5,844.17 | -5,754.26 |
| EPS Diluted Continuous Ops | -1,931.71 | -9,310.53 | -4,508.50 | -5,974.59 | -5,718.60 |
| EBITDA(a) | $-2,078 | $-6,851 | $-1,459 | $-1,796 | $-1,691 |